Why Gene Therapy + Lab Automation Is a Big Opportunity

Gene therapy is one of the fastest-growing areas in biotech, with over 1,500 trials underway and multiple FDA approvals in recent years. But the R&D process is still slow, manual, and expensive—especially when it comes to vector optimization, transfection workflows, and assay development.

Automating these processes can:

• Reduce time and labor costs in high-skill, repetitive tasks

• Improve reproducibility and eliminate human error in sensitive workflows

• Enable scalability from preclinical studies to GMP-ready manufacturing

• Make cutting-edge therapy development more accessible to smaller teams

By building modular, intelligent tools tailored for gene therapy labs, we can help accelerate the development of life-saving treatments—and open the field to more innovators.